• Return to Headlines

Shares of EXEL Down 6.5% Since Downtrend Call on Shares

By David Diaz

SmarTrend identified a Downtrend for Exelixis Inc (NASDAQ:EXEL) on April 17th, 2019 at $22.10. In approximately 2 months, Exelixis Inc has returned 6.49% as of today's recent price of $20.66.

Over the past year, Exelixis Inc has traded in a range of $13.42 to $25.31 and is now at $20.65, 54% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has declined 1.8%.

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Exelixis Inc.

Log in and add Exelixis Inc (EXEL) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights exelixis inc

Ticker(s): EXEL